InsidersTradesSigma
Follow the Marinomed Biotech AG stock price and the full insider trade history of the company, a listed equity based in Austria. Shares trade on the AT market, under the oversight of FMA (OeKB OAM). Operating in the Healthcare & Pharma sector, Marinomed Biotech AG has published 28 reports. Market capitalisation: €9.4m. The latest transaction was filed on 15 April 2026 (Purchase). Among the most active insiders: Brigitte Ederer. Every trade is openly available.
28
Insider Decl.
n/a
Thresholds
€4m
10 ops.
Buy Volume
n/a
n/a
Sell Volume
42Σ signal
Fundamental score
Ranked 4,044 of 29,063 companies
70.7
score / 100
Value57
Quality84
FCF yld-12%
Earn yld·
EV/EBITDA1.1x
ROE·
Gross mgn82%
Net mgn·
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 April 2026
Declarations28 total
357 shares@ €14.000.053% mcap1.1% of flowShareISIN ATMARINOMED6FMA:247695
357 shares@ €14.000.053% mcap1.1% of flowShareISIN ATMARINOMED6FMA:247691
1,500 shares@ €14.000.22% mcap50.0% of flowShareISIN ATMARINOMED6FMA:247198
1,500 shares@ €14.0033.3% of flowShareISIN ATMARINOMED6FMA:247196
3,521 shares@ €14.000.52% mcap66.1% of flowShareISIN AT0000A3T5H4FMA:247194
3,521 shares@ €14.000.52% mcap39.8% of flowShareISIN AT0000A3T5H4FMA:247192
33,032 shares@ €14.004.92% mcap98.9% of flowShareISIN AT0000A3T5H4FMA:247190
33,032 shares@ €14.004.92% mcap98.9% of flowShareISIN AT0000A3T5H4FMA:247186
7,885 shares@ €14.701.23% mcap100.0% of flowShareISIN ATMARINOMED6FMA:217081
1,500 shares@ €14.000.22% mcap50.0% of flowShareISIN ATMARINOMED6FMA:216982
5,053 shares@ €5.000.27% mcap33.9% of flowShareISIN ATMARINOMED6FMA:204313
5,634.4 shares@ €37.56272.25% mcap0.1% of flowShareVienna Stock Exchange MICISIN ATMARINOMED6FMA:187466
6,320 shares@ €63.204.25% mcap0.2% of flowShareVienna Stock Exchange MICISIN ATMARINOMED6FMA:178676
632,000 shares@ €63.2020.2% of flowShareVienna Stock Exchange MICISIN ATMARINOMED6FMA:178670
1,772,340 shares@ €88.61779.5% of flowShareVienna Stock Exchange MICISIN ATMARINOMED6FMA:166067
16,200 shares@ €90.0015.52% mcap50.9% of flowShareOutside a trading venue NewsISIN ATMARINOMED6FMA:165265
18,750 shares@ €75.0049.1% of flowShareOutside a trading venue NewsISIN ATMARINOMED6FMA:149376
25 of 28 declarations
Acerca de Marinomed Biotech AG
Marinomed Biotech AG es una empresa biofarmacéutica centrada en el desarrollo de tratamientos antivirales y vacunas. Se especializa en soluciones innovadoras para enfermedades virales e infecciones respiratorias.
